Penn Medicine Provider
Pathology and Laboratory Medicine
Eitan Halper-Stromberg, MD, PhD
Accepting new patients
Sees patients age 18 and up
Penn Pathology and Laboratory Medicine HUP

About me

  • Assistant Professor of Clinical Pathology and Laboratory Medicine

Education and training

  • Medical School: University of Colorado
  • Residency: Johns Hopkins Hospital
  • Fellowship: Johns Hopkins Hospital

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Halper-Stromberg is a Penn Medicine physician.

Qualifications and experience

My research

Eric C. Honaker, Laura M. Warmke, Ameline Baptiste, Daniel Baumhoer, Esther Baranov, Eitan Halper-Stromberg, Carina A. Dehner CD34-Positive Acral Chondromyxoid Mesenchymal Neoplasm Harboring a Novel TCF4::ERG Fusion , Genes, Chromosomes and Cancer, 64(8): 2025


Cappadocia J, Maxwell KN, Nathanson KL, Bagley S, Powers J, Halper-Stromberg E, Roth JJ, Domchek S, Shah PD. Exploration of possible association of BRIP1 pathogenic variants with central nervous system cancers in an institutional cohort , J Med Genet: 2025


Mawalkar, Resham; Tsai, Hua-Ling; Jouaneh, Terra Marie M; Patel, Shivam; Gocke, Christopher; Halper-Stromberg, Eitan; Xian, Rena R; Rappazzo, K C; Braunstein, Evan M; Moliterno, Alison R; Jain, Tania igh Molecular Risk Mutations (HMR) Drive Progression of CALR -Mutated Myeloproliferative Neoplasm (MPN) , Blood, 144(Supplement 1): 2024,3173


R Colbourn, R Ramesh, V Van Deerlin, E Halper-Stromberg A Statistical Method for Analysis of T Cell Clonality by Next Generation Sequencing of the T Cell Receptor Gamma Gene , Journal of Molecular Diagnostics, 26(11): 2024,S76-S76


Kalghatgi, T., Von Reusner, J. Halper-Stromberg, E Evaluating Performance of LLMs for Generating Information That Would Appear on a Molecular Pathology Report and Genetic Variant Classification in Molecular Pathology , Journal of Molecular Diagnostics, 26(11): 2024,S73-S74


R Ramesh, R Colbourn, V Van Deerlin, E Halper-Stromberg Measuring T Cell Diversity Alongside Clonality May Prove Clinically Useful for Patients Undergoing NGS-Based T Cell Receptor Gamma Gene (TRG) Rearrangement Testing , Journal of Molecular Diagnostics, 26(11): 2024,S37-S37


Halper-Stromberg E, Stinnett V, Morsberger L, Pallavajjala A, Levis MJ, DeZern AE, Lei M, Phan B, Xian RR, Gocke CD, Tang G, Zou YS. 1q jumping translocation as a biomarker in myeloid malignancy: frequently mutated genes associated with bad prognosis and low survival , Exp Hematol Oncol, 13: 2024,73


Selina Shiqing K Teh, Akhil Kotwal, Eitan Halper-Stromberg, Laura Morsberger, Kirsten Bowland, Alexis Bennett, Michael Goldstein, Ying S Zou, James R Eshleman Simultaneous CRISPR-Cas9 induced double strand breaks causes chromosomal catastrophe in pancreatic cancers: A parallel comparison with ionizing radiation , Cancer Research, 84(7 Supplement): 2024,LB397-LB397


Rimal, A., Halper-Stromberg, E Making Semi-structured Molecular Pathology Information More Accessible and Searchable Using Vector Store Indices , Journal of Molecular Diagnostics, 26(11): 2024,S86-S87


Teh, Selina Shiqing K; Bowland, Kirsten; Bennett, Alexis; Halper-Stromberg, Eitan; Skaist, Alyza; Pallavajjala, Aparna; Tang, Jacqueline; Cai, Fidel; Liang, Hong; Wheelan, Sarah; Scharpf, Robert B; Roberts, Nicholas J; Eshleman, James R Novel PAMs from Somatic Mutations Produce Numerous Pancreatic Cancer-Specific CRISPR-Cas9 Targets for Selective Cell Elimination: A Novel Gene Therapy Approach for Cancer , Molecular cancer therapeutics, 22(12_Supplement): 2023,LB_B02-LB_B02